Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection

American Journal of Tropical Medicine and Hygiene

Volumn 71, Issue 4, 2004, Pages 407-411

  Vanloubbeeck, Yannick ^a   Jones, Douglas E ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CELLULAR IMMUNODEFICIENCY; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RESISTANCE; INTERFERON PRODUCTION; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE CELL; MOUSE; NONHUMAN; PARASITE VIRULENCE; PHENOTYPE; PROMASTIGOTE; PROTEIN DETERMINATION; TH1 CELL;

ANIMALIA; LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR; PROTOZOA;

EID: 7644238380     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2004.71.407     Document Type: Article

References (42)

1. Grevelink SA, Lerner EA, 1996. Leishmaniasis. J Am Acad Dermatol 34: 257-272.
2. Marsella R, Ruiz de Gopegui R, 1998. Leishmaniasis: a re-emerging zoonosis. Int J Dermatol 37: 801-814.
3. Barral A, Pedral-Sampaio D, Grimaldi G Jr, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaro R, Barral-Netto M, Carvalho EM, Johnson WD Jr, 1991. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44: 536-546.
4. Sacks D, Noben-Trauth N, 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845-858.
5. Afonso LC, Scott P, 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952-2959.
6. Jones DE, Buxbaum LU, Scott P, 2000. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol 165: 364-372.
7. Jones DE, Ackermann MR, Wille U, Hunter CA, Scott P, 2002. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun 70: 2151-2158.
8. + T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol 158: 5374-5383.
9. Ji J, Sun J, Soong L, 2003. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278-4288.
10. Padigel UM, Alexander J, Farrell JP, 2003. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol 171: 3705-3710.
11. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK, 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177: 1505-1509.
12. Kane MM, Mosser DM, 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166: 1141-1147.
13. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM, 1990. Cure of murine leishmaniasis with antiinterleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171: 115-127.
14. Chatelain R, Varkila K, Coffman RL, 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 148: 1182-1187.
15. Alexander J, Phillips RS, 1978. Leishmania tropica and Leishmania mexicana: cross-immunity in mice. Exp Parasitol 45: 93-100.
16. Perez H, Arredondo B, Machado R, 1979. Leishmania mexicana and Leishmania tropica: cross immunity in C57BL/6 mice. Exp Parasitol 48: 9-14.
17. Alexander J, 1982. A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana. Trans R Soc Trop Med Hyg 76: 646-649.
18. Howard JG, Nicklin S, Hale C, Liew FY, 1982. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol 129: 2206-2212.
19. Howard JG, Liew FY, Hale C, Nicklin S, 1984. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J Immunol 132: 450-455.
20. Alexander J, Kaye PM, 1985. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Clin Exp Immunol 61: 674-682.
21. Frommel D, Ogunkolade BW, Vouldoukis I, Monjour L, 1988. Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice. Infect Immun 56: 843-848.
22. Mitchell GF, Handman E, 1987. Heterologous protection in murine cutaneous leishmaniasis. Immunol Cell Biol 65: 387-392.
23. Neal RA, Reeves A, Peters W, 1990. Leishmania infecting man and wild animals in Saudi Arabia. 7. Partial protection of mice against Leishmania major by prior infection with L. arabica. Trans R Soc Trop Med Hyg 84: 233-238.
24. Soong L, Duboise SM, Kima P, McMahon-Pratt D, 1995. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect Immun 63: 3559-3566.
25. Veras P, Brodskyn C, Balestieri F, Freitas L, Ramos A, Queiroz A, Barral A, Beverley S, Barral-Netto M, 1999. A dhfr-ts-Leishmania major knockout mutant cross-protects against Leishmania amazonensis. Mem Inst Oswaldo Cruz 94: 491-496.
26. Bebars MA, el Serougi AO, Makled KM, Mikhael EM, Abou Gamra MM, el Sherbiny M, Mohareb AW, Mohammed EA, 2000. An experimental vaccine providing heterologous protection for Leishmania species in murine model. J Egypt Soc Parasitol 30: 137-156.
27. Campbell K, Diao H, Ji J, Soong L, 2003. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis. Infect Immun 71: 6270-6278.
28. + T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect Immun 71: 3172-3182.
29. Pinto EF, de Mello Cortezia M, Rossi-Bergmann B, 2003. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis. Vaccine 21: 3534-3541.
30. Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP, 2003. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71: 3988-3994.
31. Lainson R, Bray RS, 1966. Studies on the immunology and serology of leishmaniasis. II. Cross-immunity experiments among different forms of American cutaneous leishmaniasis in monkeys. Trans R Soc Trop Med Hyg 60: 526-532.
32. Lainson R, Shaw JJ, 1977. Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis. J Trop Med Hyg 80: 29-35.
33. Gicheru MM, Olobo JO, Anjili CO, 1997. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Exp Parasitol 85: 109-116.
34. Lainson R, Shaw JJ, 1966. Studies on the immunology and serology of leishmaniasis. 3. on the cross-immunity between Panamanian cutaneous leishmaniasis and Leishmania mexicana infection in man. Trans R Soc Trop Med Hyg 60: 533-535.
35. Peters W, Bryceson A, Evans DA, Neal RA, Kaye P, Blackwell J, Killick-Kendrick R, Liew FY, 1990. Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man. Trans R Soc Trop Med Hyg 84: 681-689.
36. Champsi J, McMahon-Pratt D, 1988. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect Immun 56: 3272-3279.
37. Beyrodt CG, Pinto AR, Freymuller E, Barbieri CL, 1997. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Infect Immun 65: 2052-2059.
38. Chen G, Darrah PA, Mosser DM, 2001. Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages. Infect Immun 69: 3255-3263.
39. Jones D, Elloso MM, Showe L, Williams D, Trinchieri G, Scott P, 1998. Differential regulation of the interteukin-12 receptor during the innate immune response to Leishmania major. Infect Immun 66: 3818-3824.
40. + T cells resulting in a state of unresponsiveness to IL-12. J Immunol 161: 6156-6163.
41. + T cells during a Th2 response in Leishmania major-infected mice. Eur J Immunol 30: 2007-2014.
42. Barral-Netto M, Von Sohsten RL, Teixeira M, dos Santos WL, Pompeu ML, Moreira RA, Oliveira JT, Cavada BS, Falcoff E, Barral A, 1996. In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensis. Acta Trop 60: 237-250.